![]() |
Arcellx, Inc. (ACLX) DCF -Bewertung
US | Healthcare | Biotechnology | NASDAQ
|

- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Arcellx, Inc. (ACLX) Bundle
Möchten Sie den inneren Wert von Arcellx, Inc. beurteilen? Unser ACLX DCF-Taschenrechner bietet neben umfassenden Anpassungsfunktionen reale Daten, mit denen Sie Ihre Prognosen verfeinern und Ihre Investitionsentscheidungen verbessern können.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | .0 | .0 | .0 | 110.3 | 107.9 | 107.4 | 106.8 | 106.2 | 105.6 | 105.1 |
Revenue Growth, % | 0 | 0 | 0 | 0 | -2.16 | -0.54002 | -0.54002 | -0.54002 | -0.54002 | -0.54002 |
EBITDA | -31.5 | -63.9 | -184.7 | -64.1 | -99.1 | 32.2 | 32.0 | 31.9 | 31.7 | 31.5 |
EBITDA, % | 100 | 100 | 100 | -58.15 | -91.78 | 30.02 | 30.02 | 30.02 | 30.02 | 30.02 |
Depreciation | .6 | 1.0 | 2.2 | 2.0 | 5.2 | 65.8 | 65.5 | 65.1 | 64.8 | 64.4 |
Depreciation, % | 100 | 100 | 100 | 1.85 | 4.81 | 61.33 | 61.33 | 61.33 | 61.33 | 61.33 |
EBIT | -32.1 | -65.0 | -187.0 | -66.2 | -104.2 | 30.8 | 30.6 | 30.5 | 30.3 | 30.1 |
EBIT, % | 100 | 100 | 100 | -59.99 | -96.58 | 28.68 | 28.68 | 28.68 | 28.68 | 28.68 |
Total Cash | 46.6 | 104.6 | 254.8 | 702.0 | 587.4 | 107.4 | 106.8 | 106.2 | 105.6 | 105.1 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | .0 | .0 | .0 | .0 | .0 | 64.4 | 64.1 | 63.7 | 63.4 | 63.0 |
Account Receivables, % | 100 | 100 | 100 | 0 | 0 | 60 | 60 | 60 | 60 | 60 |
Inventories | .0 | .0 | .0 | .0 | .0 | 64.4 | 64.1 | 63.7 | 63.4 | 63.0 |
Inventories, % | 100 | 100 | 100 | 0 | 0 | 60 | 60 | 60 | 60 | 60 |
Accounts Payable | .5 | 1.3 | 9.1 | 2.6 | 2.1 | 65.3 | 65.0 | 64.6 | 64.3 | 63.9 |
Accounts Payable, % | 100 | 100 | 100 | 2.37 | 1.94 | 60.86 | 60.86 | 60.86 | 60.86 | 60.86 |
Capital Expenditure | -.9 | -5.8 | -2.3 | -21.4 | -13.4 | -6.8 | -6.8 | -6.8 | -6.7 | -6.7 |
Capital Expenditure, % | 100 | 100 | 100 | -19.42 | -12.45 | -6.37 | -6.37 | -6.37 | -6.37 | -6.37 |
Tax Rate, % | -1.97 | -1.97 | -1.97 | -1.97 | -1.97 | -1.97 | -1.97 | -1.97 | -1.97 | -1.97 |
EBITAT | -32.1 | -63.9 | -184.4 | -66.8 | -106.3 | 30.6 | 30.4 | 30.3 | 30.1 | 30.0 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -31.9 | -67.8 | -176.7 | -92.6 | -115.1 | 24.0 | 89.5 | 89.0 | 88.5 | 88.0 |
WACC, % | 5.5 | 5.5 | 5.5 | 5.5 | 5.5 | 5.5 | 5.5 | 5.5 | 5.5 | 5.5 |
PV UFCF | ||||||||||
SUM PV UFCF | 317.7 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | 90 | |||||||||
Terminal Value | 2,562 | |||||||||
Present Terminal Value | 1,960 | |||||||||
Enterprise Value | 2,278 | |||||||||
Net Debt | -52 | |||||||||
Equity Value | 2,330 | |||||||||
Diluted Shares Outstanding, MM | 54 | |||||||||
Equity Value Per Share | 43.49 |
What You Will Receive
- Authentic Arcellx Data: Preloaded financial metrics – from revenue to EBIT – based on real and projected figures.
- Complete Customization: Modify all essential parameters (yellow cells) such as WACC, growth %, and tax rates.
- Immediate Valuation Updates: Automatic recalculations to assess the impact of changes on Arcellx’s fair value.
- Flexible Excel Template: Designed for quick modifications, scenario analysis, and comprehensive projections.
- Efficient and Accurate: Eliminate the need to build models from scratch while ensuring precision and adaptability.
Key Features
- Pre-Loaded Data: Arcellx, Inc.'s historical financial statements and pre-filled forecasts.
- Fully Adjustable Inputs: Modify WACC, tax rates, revenue growth, and EBITDA margins.
- Instant Results: Observe Arcellx, Inc.'s intrinsic value update in real time.
- Clear Visual Outputs: Dashboard charts present valuation results and essential metrics.
- Built for Accuracy: A professional tool designed for analysts, investors, and finance professionals.
How It Works
- Step 1: Download the Excel file for Arcellx, Inc. (ACLX).
- Step 2: Review the pre-filled financial data and forecasts for Arcellx, Inc. (ACLX).
- Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model update in real-time as you modify your assumptions.
- Step 5: Evaluate the outputs and leverage the results for your investment decisions.
Why Choose the Arcellx Calculator?
- Accuracy: Utilizes real Arcellx financial data for precise calculations.
- Flexibility: Built for users to easily adjust and manipulate inputs.
- Time-Saving: Eliminate the need to create a financial model from the ground up.
- Professional-Grade: Crafted with the precision and usability expected by top executives.
- User-Friendly: Intuitive design makes it accessible for users without extensive financial modeling expertise.
Who Can Benefit from This Product?
- Investors: Accurately assess Arcellx, Inc.'s (ACLX) intrinsic value before making investment choices.
- CFOs: Utilize a high-quality DCF model for comprehensive financial reporting and analysis.
- Consultants: Easily customize the template for client valuation reports.
- Entrepreneurs: Discover financial modeling techniques employed by leading companies.
- Educators: Incorporate it as a resource to illustrate valuation methods in the classroom.
Contents of the Template
- Pre-Filled Data: Features Arcellx, Inc.'s historical financials and projections.
- Discounted Cash Flow Model: Customizable DCF valuation model with automatic calculations.
- Weighted Average Cost of Capital (WACC): A separate sheet for determining WACC based on user-defined inputs.
- Key Financial Ratios: Evaluate Arcellx's profitability, operational efficiency, and financial leverage.
- Customizable Inputs: Easily modify revenue growth rates, profit margins, and tax rates.
- Clear Dashboard: Visuals and tables summarizing essential valuation outcomes.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.